imatinib mesylate has been researched along with DDD MPGNII in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawachi, H; Khadzhynov, D; Loof, T; Mika, A; Neumayer, HH; Peters, H; Wang-Rosenke, Y | 1 |
| Alpers, CE; Banas, MC; Becker-Herman, S; Guo, S; Hudkins, KL; Iyoda, M; Kowalewska, J; Liu, G; Meyer-Bahlburg, A; Rawlings, DJ; Wietecha, TA; Ziegler, SF | 1 |
| Kilara, N; Manjunath, R; Mysorekar, V; Subramanian, M | 1 |
| Fogo, AB; Schulman, G; Wallace, E | 1 |
| Hirai, T; Kohno, N; Kuratsune, M; Masaki, T; Yorioka, N | 1 |
| Dwyer, JP; Fogo, AB; Koury, MJ; Stone, WJ; Sumner, EL; Wang, Y; Yates, KM; Zent, R | 1 |
| Atkins, RC; Chadban, S; Cooper, ME; Gilbert, RE; Hill, PA; Kelly, DJ; McKay, T; Nikolic-Paterson, DJ | 1 |
7 other study(ies) available for imatinib mesylate and DDD MPGNII
| Article | Year |
|---|---|
Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat.
Topics: Animals; Benzamides; Chronic Disease; Disease Progression; Glomerulonephritis, Membranoproliferative; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Wistar; Thy-1 Antigens; Treatment Outcome | 2013 |
Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis.
Topics: Animals; B-Lymphocytes; Benzamides; Complement C3; Cryoglobulinemia; Cytokines; Female; Glomerulonephritis, Membranoproliferative; Imatinib Mesylate; Lymphocyte Activation; Male; Mice; Mice, Transgenic; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thymic Stromal Lymphopoietin | 2009 |
Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia.
Topics: Adult; Antineoplastic Agents; Benzamides; Diuretics; Glomerulonephritis, Membranoproliferative; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Philadelphia Chromosome; Piperazines; Pyrimidines; Treatment Outcome | 2010 |
Imatinib therapy for non-infection-related type II cryoglobulinemia with membranoproliferative glomerulonephritis.
Topics: Benzamides; Cryoglobulinemia; Glomerulonephritis, Membranoproliferative; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2012 |
PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation.
Topics: Animals; Antibodies, Monoclonal; Benzamides; Cell Division; Cell Line; Glomerulonephritis, Membranoproliferative; Imatinib Mesylate; Immunohistochemistry; Isoantibodies; Male; Mesangial Cells; Phosphorylation; Piperazines; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Receptors, Platelet-Derived Growth Factor; STAT3 Transcription Factor | 2006 |
Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy.
Topics: Benzamides; Biopsy; Bone Marrow; Disease Progression; Follow-Up Studies; Glomerular Basement Membrane; Glomerulonephritis, Membranoproliferative; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mesangial Cells; Microscopy, Electron; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines | 2007 |
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Topics: Animals; Benzamides; Cell Division; Cell Line; Collagen; Enzyme Inhibitors; Fibroblast Growth Factor 2; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imatinib Mesylate; Kidney Glomerulus; Male; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Wistar; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Thy-1 Antigens | 2001 |